The Rationale for Initiating Treatment of Hypercholesterolemia in Young Adulthood.
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 1, p. 1, doi. 10.1007/s11883-012-0296-2
- By:
- Publication type:
- Article
Works matching IS 15233804 AND DT 2013 AND VI 15 AND IP 1
Results: 7
1
2
Moving Beyond JUPITER: Will Inhibiting Inflammation Reduce Vascular Event Rates?
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 1, p. 1, doi. 10.1007/s11883-012-0295-3
- By:
- Publication type:
- Article
3
Is Atherosclerosis Regression a Realistic Goal of Statin Therapy and What Does That Mean?
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 1, p. 1, doi. 10.1007/s11883-012-0294-4
- By:
- Publication type:
- Article
4
Does it Make Sense to Combine Statins with Other Lipid-Altering Agents Following AIM-HIGH, SHARP and ACCORD?
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 1, p. 1, doi. 10.1007/s11883-012-0290-8
- By:
- Publication type:
- Article
5
Vitamin D, Calcium, and Atherosclerotic Risk: Evidence from Serum Levels and Supplementation Studies.
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 1, p. 1, doi. 10.1007/s11883-012-0293-5
- By:
- Publication type:
- Article
6
How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy?
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 1, p. 1, doi. 10.1007/s11883-012-0291-7
- By:
- Publication type:
- Article
7
Lipid Effects of Psychiatric Medications.
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 1, p. 1, doi. 10.1007/s11883-012-0292-6
- By:
- Publication type:
- Article